Citius Pharmaceuticals
CTXR
$0.70
Share price
-0.28%
Change (1 day)
-43.60%
Change (1 year)
Categories
EPS for Citius Pharmaceuticals (CTXR)
EPS in 2023 (TTM): -$0.20
According to Citius Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$0.20. In 2022 the company made an earnings per share (EPS) of -$0.18 a decrease over its 2021 EPS that were of -$0.18.
EPS history for Citius Pharmaceuticals from 2011 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.20 | 11.11% |
| 2022 | -$0.18 | -0% |
| 2021 | -$0.18 | -60.87% |
| 2020 | -$0.46 | -35.21% |
| 2019 | -$0.71 | -31.07% |
| 2018 | -$1.03 | -43.72% |
| 2017 | -$1.83 | -8.5% |
| 2016 | -$2.00 | 19.76% |
| 2015 | -$1.67 | 132.16% |
| 2014 | -$0.72 | -2.73% |
| 2013 | -$0.74 | 3486.36% |
| 2012 | -$0.02062 | 502.25% |
| 2011 | -$0.003424 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 990.00% | 🇺🇸 USA |